Wall Street Moves on MAA, Rivian and Design Therapeutics: One Upgrade, One Target Trim and a Biotech on Watch

Summary

Wall Street commentary mentions Design Therapeutics alongside updates on MAA and Rivian, including an upgrade, target trim, and biotech on watch. Insufficient detail provided in the article excerpt to determine specific catalysts or financial impact.